Literature DB >> 29894597

Trends in Illicit Drug Use Among Smokers and Nonsmokers in the United States, 2002-2014.

Scott J Moeller1, David S Fink2, Misato Gbedemah3, Deborah S Hasin2,4,5, Sandro Galea6, Michael J Zvolensky7,8, Renee D Goodwin9,2,3.   

Abstract

OBJECTIVE: Cigarette smoking has declined in the United States. Still, identifying prevalent and modifiable barriers to quitting can help inform the next steps for tobacco control. Illicit drug use, which may be increasingly common in the United States, could be one such factor. We investigated the relationship between past-month illicit drug use and cigarette smoking status and estimated trends in the prevalence of past-month illicit drug use by cigarette smoking status from 2002 to 2014 in the United States.
METHODS: The 2002-2014 National Survey on Drug Use and Health was used to obtain nationally representative data on past-month illicit drug use.
RESULTS: From 2002 to 2014, past-month illicit drug use (for all drugs considered) was nearly 5 times more common among current smokers than among never smokers (adjusted odds ratio = 4.79) and nearly twice as prevalent in former smokers as in never smokers (adjusted odds ratio = 1.99). Illicit drug use increased linearly over time from 2002 to 2014 in the entire general population (ie, across and within current smokers, former smokers, and never smokers). This increasing trend in drug use was most rapid among former smokers (relative to current smokers and never smokers) and was largely, but not entirely, driven by increases in cannabis use.
CONCLUSIONS: Illicit drug use is most prevalent among current cigarette smokers. Yet, the rate of increase in illicit drug use prevalence was most rapid among former smokers. Because former smokers outnumber current smokers in the general population, it may be important to monitor former smokers into the future for potential negative drug-related outcomes. © Copyright 2018 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29894597      PMCID: PMC6139671          DOI: 10.4088/JCP.17m11718

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  48 in total

Review 1.  A review of co-morbid tobacco and cannabis use disorders: possible mechanisms to explain high rates of co-use.

Authors:  Rachel Allison Rabin; Tony Peter George
Journal:  Am J Addict       Date:  2015-02-06

2.  Co-occurring risk factors for current cigarette smoking in a U.S. nationally representative sample.

Authors:  Stephen T Higgins; Allison N Kurti; Ryan Redner; Thomas J White; Diana R Keith; Diann E Gaalema; Brian L Sprague; Cassandra A Stanton; Megan E Roberts; Nathan J Doogan; Jeff S Priest
Journal:  Prev Med       Date:  2016-02-21       Impact factor: 4.018

3.  The role of mental illness on cigarette dependence and successful quitting in a nationally representative, household-based sample of U.S. adults.

Authors:  Valerie L Forman-Hoffman; Sarra L Hedden; Cristie Glasheen; Christine Davies; Lisa J Colpe
Journal:  Ann Epidemiol       Date:  2016-05-12       Impact factor: 3.797

4.  Cigarette smoking behaviors among adults with serious mental illness in a nationally representative sample.

Authors:  Cristie Glasheen; Sarra L Hedden; Valerie L Forman-Hoffman; Lisa J Colpe
Journal:  Ann Epidemiol       Date:  2014-07-30       Impact factor: 3.797

5.  Achieving the tobacco endgame: evidence on the hardening hypothesis from repeated cross-sectional studies in New Zealand 2008-2014.

Authors:  Richard Edwards; Danny Tu; Rhiannon Newcombe; Kate Holland; Darren Walton
Journal:  Tob Control       Date:  2016-07-05       Impact factor: 7.552

6.  The widening gender gap in marijuana use prevalence in the U.S. during a period of economic change, 2002-2014.

Authors:  Hannah Carliner; Pia M Mauro; Qiana L Brown; Dvora Shmulewitz; Reanne Rahim-Juwel; Aaron L Sarvet; Melanie M Wall; Silvia S Martins; Geoffrey Carliner; Deborah S Hasin
Journal:  Drug Alcohol Depend       Date:  2016-11-11       Impact factor: 4.492

7.  Association between cigarette smoking and anxiety disorders during adolescence and early adulthood.

Authors:  J G Johnson; P Cohen; D S Pine; D F Klein; S Kasen; J S Brook
Journal:  JAMA       Date:  2000-11-08       Impact factor: 56.272

8.  Smoking and mental illness in the U.S. population.

Authors:  Philip H Smith; Carolyn M Mazure; Sherry A McKee
Journal:  Tob Control       Date:  2014-04-12       Impact factor: 7.552

9.  Epidemiology of DSM-5 Drug Use Disorder: Results From the National Epidemiologic Survey on Alcohol and Related Conditions-III.

Authors:  Bridget F Grant; Tulshi D Saha; W June Ruan; Risë B Goldstein; S Patricia Chou; Jeesun Jung; Haitao Zhang; Sharon M Smith; Roger P Pickering; Boji Huang; Deborah S Hasin
Journal:  JAMA Psychiatry       Date:  2016-01       Impact factor: 21.596

10.  Prevalence of hardcore smoking in the Netherlands between 2001 and 2012: a test of the hardening hypothesis.

Authors:  Jeroen Bommelé; Gera E Nagelhout; Marloes Kleinjan; Tim M Schoenmakers; Marc C Willemsen; Dike van de Mheen
Journal:  BMC Public Health       Date:  2016-08-09       Impact factor: 3.295

View more
  10 in total

1.  Prevalence and patterns of opioid misuse and opioid use disorder among primary care patients who use tobacco.

Authors:  William S John; He Zhu; Paolo Mannelli; Geetha A Subramaniam; Robert P Schwartz; Jennifer McNeely; Li-Tzy Wu
Journal:  Drug Alcohol Depend       Date:  2018-11-26       Impact factor: 4.492

2.  Patterns and Frequency of Current e-Cigarette Use in United States Adults.

Authors:  Maria A Parker; Andrea C Villanti
Journal:  Subst Use Misuse       Date:  2019-06-21       Impact factor: 2.164

3.  Smoking relapse risk is increased among individuals in recovery.

Authors:  Amanda J Quisenberry; Jami Pittman; Renee D Goodwin; Warren K Bickel; Giordano D'Urso; Christine E Sheffer
Journal:  Drug Alcohol Depend       Date:  2019-07-08       Impact factor: 4.492

4.  Independent association of tobacco use with opioid use disorder in patients of European ancestry with chronic non-cancer pain.

Authors:  Martin D Cheatle; Mary Falcone; Lara Dhingra; Caryn Lerman
Journal:  Drug Alcohol Depend       Date:  2020-02-14       Impact factor: 4.492

Review 5.  Combined and sequential effects of alcohol and methamphetamine in animal models.

Authors:  Alexandra M Stafford; Bryan K Yamamoto; Tamara J Phillips
Journal:  Neurosci Biobehav Rev       Date:  2021-09-17       Impact factor: 8.989

6.  Substance Use and Performance of Toxicology Screens in the Greater Cincinnati Northern Kentucky Stroke Study.

Authors:  Tracy E Madsen; Olivia W Cummings; Felipe De Los Rios La Rosa; Jane C Khoury; Kathleen Alwell; Daniel Woo; Simona Ferioli; Sharyl Martini; Opeolu Adeoye; Pooja Khatri; Matthew L Flaherty; Jason Mackey; Eva A Mistry; Stacie L Demel; Elisheva Coleman; Adam S Jasne; Sabreena J Slavin; Kyle Walsh; Michael Star; Joseph P Broderick; Brett M Kissela; Dawn O Kleindorfer
Journal:  Stroke       Date:  2022-07-07       Impact factor: 10.170

Review 7.  One Is Not Enough: Understanding and Modeling Polysubstance Use.

Authors:  Elizabeth A Crummy; Timothy J O'Neal; Britahny M Baskin; Susan M Ferguson
Journal:  Front Neurosci       Date:  2020-06-16       Impact factor: 4.677

8.  Retrospective cross-sectional analysis of the changes in marijuana use in the USA, 2005-2018.

Authors:  William Mitchell; Roma Bhatia; Nazlee Zebardast
Journal:  BMJ Open       Date:  2020-07-28       Impact factor: 2.692

9.  Hospital indicators and inpatient behavior in a psychiatric hospital that implemented the smoking ban.

Authors:  Renata Marques de Oliveira; Jair Lício Ferreira Santos; Antônia Regina Ferreira Furegato
Journal:  Rev Lat Am Enfermagem       Date:  2022

10.  Brief original report: Does smoking status provide information relevant to screening for other substance use among US adults?

Authors:  Maria R Khan; Kaoon Ban; Ellen C Caniglia; Jennifer E Edelman; Julie Gaither; Stephen Crystal; Natalie E Chichetto; Kailyn E Young; Janet Tate; Amy C Justice; R Scott Braithwaite
Journal:  Prev Med Rep       Date:  2021-07-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.